ConductScience.org, home

Paper41821908

A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors.

Abdelrahman IFS and 7 others. Cent European J Urol, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors. Papers, record 41821908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41821908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A novel approach to Peyronie's disease: Intralesional injection of lyophilized platelet-derived growth factors.
PubMed
Journal
Cent European J Urol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abdelrahman IFSIslam Fathy Soliman
2Raheem AAAmr Abdel
3Elbitar MMahmoud
4Fahmy HHossam
5ZaaZaa AAdham
6Adel AAhmed
7Gadalla AAmr
8AbdElSalam MAMohamed Ahmed

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133754800Using intra-articular allogenic lyophilized growth factors in primary knee osteoarthritis: a randomized pilot study.Regen Med2021https://conductscience.org/library/papers/33754800PubMed
228874327Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.Sex Med Rev2017https://conductscience.org/library/papers/28874327PubMed
329761688Collagenase clostridium histolyticum: a novel medical treatment for Peyronie's disease.Minerva Urol Nefrol2018https://conductscience.org/library/papers/29761688PubMed
426516079Growth Factor Release from Lyophilized Porcine Platelet-Rich Plasma: Quantitative Analysis and Implications for Clinical Applications.Aesthetic Plast Surg2016https://conductscience.org/library/papers/26516079PubMed
528612401Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol.BJU Int2017https://conductscience.org/library/papers/28612401PubMed
622739749Advances in understanding of mammalian penile evolution, human penile anatomy and human erection physiology: clinical implications for physicians and surgeons.Med Sci Monit2012https://conductscience.org/library/papers/22739749PubMed
717888069Validation of the erection hardness score.J Sex Med2007https://conductscience.org/library/papers/17888069PubMed
825722595Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective.J Cutan Aesthet Surg2014https://conductscience.org/library/papers/25722595PubMed
940340108European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie's Disease.Eur Urol2025https://conductscience.org/library/papers/40340108PubMed
1017287870The medical management of Peyronie's disease.Nat Clin Pract Urol2007https://conductscience.org/library/papers/17287870PubMed
1133813465NON-SURGICAL TREATMENT OF PEYRONIE'S DISEASE: A COMPREHENSIVE REVIEW.Wiad Lek2021https://conductscience.org/library/papers/33813465PubMed
1225664497Responsiveness of the Peyronie's Disease Questionnaire (PDQ).J Sex Med2015https://conductscience.org/library/papers/25664497PubMed
1336721157Effectiveness of lyophilized growth factors injection for subacromial impingement syndrome: a prospective randomized double-blind placebo-controlled study.J Orthop Surg Res2023https://conductscience.org/library/papers/36721157PubMed
1426984291Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study.Sex Med2016https://conductscience.org/library/papers/26984291PubMed
1528386796Management of Peyronie's disease - a review.World J Urol2001https://conductscience.org/library/papers/28386796PubMed
1630317233The Effect of Platelet-Rich Plasma on Peyronie's Disease in Rat Model.Urol Int2019https://conductscience.org/library/papers/30317233PubMed
1729333517Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.Investig Clin Urol2018https://conductscience.org/library/papers/29333517PubMed
1822970798Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound.J Sex Med2013https://conductscience.org/library/papers/22970798PubMed
1928974406Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.J Sex Med2017https://conductscience.org/library/papers/28974406PubMed
2035778315Tolerance and efficacy of platelet-rich plasma injections in Peyronie's disease: Pilot study.Prog Urol2022https://conductscience.org/library/papers/35778315PubMed

See all 32 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41821908

GET https://conductscience.org/api/papers/v1/41821908/references?page=2